Experimental malaria vaccine promises protection for pregnant women
Two National Institutes of Health (NIH)-supported studies of an experimental malaria vaccine in healthy adults in Mali found that all three treatment regimens tested were safe. One of the studies enrolled 300 healthy women ages 18 to 38 who planned…
Groundbreaking malaria vaccine offers long-term protection for pregnant women
In a The Lancet Infectious Diseases (Safety and efficacy of PfSPZ malaria vaccine in healthy adults and women attempting to conceive in Mali: two randomized, double-blind, placebo-controlled Phase 1 and 2 trials) A team led by researchers from the Malaria…
